Kineta Announces Successful Completion of Pre-IND Meeting with the FDA for KVA12.1

Retrieved on: 2021-07-27 12:33:45

Tags for this article:

Click the tags to see associated articles and topics

Kineta Announces Successful Completion of Pre-IND Meeting with the FDA for KVA12.1. View article details on hiswai:

Excerpt

SEATTLE, July 27, 2021 /PRNewswire/ -- Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies ...

Article found on: www.prnewswire.com